Subscribe to Newsletter

Small Molecules

Discovery & Development Drug Delivery

Self-Sealing the Deal

| 3 min read

PULSED – a self-sealing drug delivery depot – enables precise timing and tunable release of therapeutic doses

Discovery & Development Drug Discovery

Power List Perspectives: Industry Breakthroughs

| Jamie Irvine | 3 min read

Pharma experts discuss the most exciting industry breakthroughs in recent years

Manufacture Small Molecules

The Dark Crystal

| Andrew Blythe-Dickens | 7 min read

Though crystallization is considered a “black art” in some circles, it’s still a crucial part of the API manufacturing process

Manufacture Small Molecules

eBook: What’s Hot in Small Molecule Drug Development?

This eBook collates some of our recent articles focusing on innovation in the small molecule space.

Discovery & Development Drug Delivery

Clever Chemistry and Cages

| Jamie Irvine | 3 min read

Self-assembling “super-sized” nanocages could encapsulate and deliver drugs to specific targets in the body.

Discovery & Development Formulation

Superbugs Versus Supercomputers

| Jamie Irvine | 2 min read

Developments in antivirulence drug treatments could solve the threat of antimicrobial resistance

Discovery & Development Formulation

The Fountain of Youth

| Jamie Irvine | 6 min read

Anti-aging company – Five Alarm Bio – reveal their discoveries on safe and effective treatments for age-associated diseases and disabilities

Discovery & Development Formulation

Llamas – and Yeast Display – to the Rescue

| Jamie Irvine | 2 min read

Modified screening process optimizes nanobodies for sustainable COVID-19 treatments derived from llamas.

Discovery & Development Drug Delivery

Power List Perspectives: Challenges Facing Cell and Gene Therapy

| Jamie Irvine

Leading pharma industry experts discuss the most pertinent challenges facing cell and gene therapy

Discovery & Development Drug Discovery

Retinal Regeneration

| 3 min read

Endogena Therapeutics CEO Matthias Steger discusses fast track FDA approval for EA-2353, a new drug for the treatment of retinitis pigmentosa

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register